Research in sleep-disordered breathing (SDB)

Research in sleep-disordered breathing

An expanding body of scientific evidence clearly indicates that sleep-disordered breathing (SDB) has a profound negative impact on public health. Through its strong partnership with the global medical community, ResMed is committed to:

Increasing awareness of the dangers of untreated SDB
Supporting ongoing research into the correlation between SDB and other health risks
Finding effective clinical solutions to improve the health and lives of SDB patients

Big data analysis

Central sleep apnoea during CPAP therapy: discover the first insights from a big data analysis.

connected-health-for-sleep-disorders-resmed

Sleep apnoea and digital connected health

Improved compliance, greater efficiencies, higher quality of care – here is some of the latest research that provides evidence of these results.

Narval CC

There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating obstructive sleep apnoea and snoring.

CSA during CPAP therapy study

Switching patients with persistent or emergent CSA from CPAP to ASV may improve compliance. Learn more about the findings from this big data study.

SERVE-HF study

SERVE-HF has become a key study in its field, contributing significantly to ASV clinical practice. Learn more about the study design, results and implications for clinical practice.

FACE study

The FACE study will provide long-term data on morbidity and mortality of heart failure (both HFrEF and HFpEF) patients using ASV.

Support for investigator initiated research

ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators.